Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice

By Kelly E.P.   Greene J.J.   King A.D.   Innis B.L.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2549-2559

Elsevier

Access to resources Recommend Favorite

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice

By Konishi E.   Yamaoka M.   Kurane I.   Mason P.W.  

Vaccine, Vol. 18, Iss. 11, 2000-01 ,pp. : 1133-1139

Elsevier

Access to resources Recommend Favorite

Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice

By Kochel T.   Wu S.-J.   Raviprakash K.   Hobart P.   Hoffman S.   Porter K.   Hayes C.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 547-552

Elsevier

Access to resources Recommend Favorite

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

By Piedra P.A.   Jewell A.M.   Cron S.G.   Atmar R.L.   Paul Glezen W.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3479-3482

Elsevier

Access to resources Recommend Favorite

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies

By Rose R.C.   Lane C.   Wilson S.   Suzich J.A.   Rybicki E.   Williamson A.-L.  

Vaccine, Vol. 17, Iss. 17, 1999-04 ,pp. : 2129-2135

Elsevier

Access to resources Recommend Favorite